Published

Current Perspectives on the Clinical Research and Medicalization of Psychedelic Drugs for Addiction Treatments: Safety, Efficacy, Limitations and Challenges.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: CNS drugs
Date: 2024-10-01
Source: PubMed
DOI: 10.1007/s40263-024-01101-3
PubMed: 39033264

Authors

Gomez-Escolar A Folch-Sanchez D Stefaniuk J Swithenbank Z Nisa A Braddick F Idrees Chaudhary N van der Meer PB Batalla A

Watch author

Derived topics and classifications

psilocybin Depression PTSD Addiction Review Article Safety Review Article

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Psilocybin in Neuropsychiatric Disorders: Seeking Valuable Evidence in History, Pure Science, Clinical Trials and Real-World Data (RWD)2026-03-26

Related papers

Characterization of Altered Waking States of Consciousness in Healthy HumansClinicalTrials.gov · 2021-04-29